New

Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →

Advertisement
ETF Central logo
Advertisement

XLVIvsPJPETF Comparison

ETF 1
XLVI

The Health Care Select Sector SPDR Premium Income Fund

This fund is part of
Options Strategies
-0.04%
Full XLVI fund page
VS
ETF 2
PJP

Invesco Dynamic Pharmaceuticals ETF

This fund is part of
US Health Care
-0.31%
Full PJP fund page

The Health Care Select Sector SPDR Premium Income Fund (XLVI) belongs to the Options Strategies segment. Invesco Dynamic Pharmaceuticals ETF (PJP) is part of the US Health Care segment. Both ETFs have the same top 3 sector exposures: and Health Care. XLVI is less expensive with a Total Expense Ratio (TER) of 0.35%, versus 0.57% for PJP. XLVI is up 0.28% year-to-date (YTD) with +$2M in YTD flows. PJP performs better with 0.96% YTD performance, and +$89M in YTD flows. Run a side-by-side ETF comparison of XLVI and PJP below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

XLVI vs PJP performance and flow charts

Performance

-4.0-3.0-2.0-1.00.01.02.0%Feb 11Feb 19Feb 26Mar 5

Cumulative Flows

0 M2 M4 M6 M8 MFeb 11Feb 19Feb 26Mar 5

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 03/11/2026
1M3MYTD1Y3Y5Y
Perf.
XLVI
PJP
-1.07%-3.66%
+1.89%+0.35%
+0.28%+0.96%
n/a+25.49%
n/a+46.89%
n/a+39.70%
Flows
XLVI
PJP
+$788K+$6M
+$3M+$93M
+$2M+$89M
-+$91M
-+$6M
--$49M
Volatility and drawdown
3M1Y3Y5Y
Volatility
XLVI
PJP
+10.15%+14.70%
n/a+18.60%
n/a+15.30%
n/a+15.87%
Max drawdown
XLVI
PJP
-3.26%-5.17%
n/a-13.71%
n/a-16.11%
n/a-17.41%
Max drawdown duration
XLVI
PJP
10d31d
n/a130d
n/a275d
n/a788d
Trading data

Create an account to view trading data

Join for free
XLVI
PJP
Last sale
3/11/2026 at 7:59 PM
$25.92
$103.91
Previous close
03/11/2026
$25.98
$105.46
Consolidated volume
03/11/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of February 27, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

XLVI
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
XLVI
PJP
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 3/11/2026 at 7:59 PM
Live
Closed
XLVI
PJP
Last price
$25.92
$103.91
1D performance
-0.23%
-1.47%
AuM$13.24 M$406.31 M
E/R0.35%0.57%
Characteristics
XLVI
PJP
Management strategyActivePassive
ProviderSPDRInvesco
Benchmark-Dynamic Pharmaceutical Intellidex Index
N° of holdings5729
Asset class-Equities
Trailing 12m distribution yield
Join
Join
Inception dateJuly 30, 2025June 23, 2005
ESGNoNo
Advertisement
Exposure

Countries

XLVI
USA
96.37%
Other
3.63%
PJP
USA
94.29%
Other
5.71%

Sectors

XLVI
Health Care
97.65%
Other
2.35%
PJP
Health Care
100%
Other
0%
Advertisement

Diversification

XLVI

Total weight of top 15 holdings out of 15

69.69%
PJP

Total weight of top 15 holdings out of 15

63.87%

Top 15 holdings

Data as of January 31, 2026
XLVI
LILLY
14.60%
JOHNSON&JOHNSON
9.71%
ABBVIE
6.99%
MERCK & CO INC
4.85%
UNITEDHEALTH GRP
4.61%
THERMO FISHER SCIENTIFIC
3.85%
ABBOTT LABS
3.37%
AMGEN-T
3.26%
INTUITIVE SURGICAL
3.17%
GILEAD SCIENCES
3.12%
PFIZER
2.66%
BOSTON SCIENTIFIC
2.46%
DANAHER
2.44%
MEDTRONIC PLC
2.34%
STRYKER
2.25%
PJP
GILEAD SCIENCES
5.53%
JOHNSON&JOHNSON
5.40%
MERCK & CO INC
5.37%
AMGEN-T
5.26%
PFIZER
5.15%
LILLY
5.00%
ABBVIE
4.83%
ABBOTT LABS
4.30%
LIQUIDIA CORPORATION
3.93%
VIATRIS INC
3.47%
BRISTOL-MYERS SQUIBB
3.18%
PRESTIGE CONSUMER HEALTHCARE
3.18%
PERRIGO CO PLC
3.15%
AMNEAL PHARMACEUTICALS INC
3.11%
SUPERNUS PHARMACEUTICALS
3.03%
Frequently asked questions about XLVI and PJP

How have the XLVI and PJP ETFs performed in 2026?

As of March 11, 2026, XLVI is up 0.28% year-to-date (YTD), while PJP has returned 0.96%. That puts PJP better performer ahead so far this year.

Which ETF is attracting more investor money: XLVI or PJP?

Year-to-date, the XLVI ETF saw +$2M in flows, compared to +$89M for PJP.

Which ETF is bigger: XLVI or PJP?

As of March 11, 2026, XLVI holds $13.24 M in assets under management (AUM), while PJP manages $406.31 M.

What sectors do the XLVI and PJP ETFs invest in?

XLVI leans toward sectors like Health Care. Meanwhile, PJP focuses on Health Care.

What are the top holdings of the XLVI ETF and PJP ETF?

XLVI top holdings include LILLY, JOHNSON&JOHNSON and ABBVIE. PJP holds in its top three: GILEAD SCIENCES, JOHNSON&JOHNSON and MERCK & CO INC.

Which ETF is more diversified: XLVI or PJP?

XLVI holds 60 securities with 69.69% of its assets in the top 15. PJP has 29 securities and a top 15 weight of 63.87%.

Advertisement
Advertisement
Advertisement
The Active Trader Report

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up

Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up